Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
Lotte Van der Weijst*, Miguel E Aguado-Barrera, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck, Patricia Calvo-Crespo, Jenny Chang-Claude, Ananya Choudhury, Gilles Defraene, Sylvian Demontois, Alison M Dunning, Rebecca M Elliott, Dawn Ennis, Corinne Faivre-Finn, Marzia Franceschini, Sara Gutiérrez-Enríquez, Carsten Herskind, Daniel S HigginsonSarah L Kerns, Kerstie Johnson, Meritxell Mollà, Maarten Lambrecht, Mónica Ramos, Tiziana Rancati, Andreas Rimner, Barry S Rosenstein, Dirk De Ruysscher, Ahmed Salem, Claudia Sangalli, Petra Seibold, Paloma Sosa-Fajardo, Elena Sperk, Hilary Stobart, Holly Summersgill, Veerle Surmont, Paul Symonds, Begoña Taboada-Lorenzo, Christopher J Talbot, Riccardo Valdagni, Ana Vega, Liv Veldeman, Marlon R Veldwijk, Tim Ward, Adam Webb, Catharine M L West, Yolande Lievens, REQUITE consortium
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)'. Together they form a unique fingerprint.